| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
RenovoRx Inc. Common Stock (NASDAQ: RNXT)
RNXT Technical Analysis
5
| As on 9th Jun 2023 RNXT STOCK Price closed @ 1.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.61 & Strong Sell for SHORT-TERM with Stoploss of 4.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RNXTSTOCK Price
| Open | 1.94 | Change | Price | % |
| High | 2.02 | 1 Day | -0.01 | -0.51 |
| Low | 1.91 | 1 Week | 0.04 | 2.11 |
| Close | 1.94 | 1 Month | -0.80 | -29.20 |
| Volume | 28100 | 1 Year | -3.54 | -64.60 |
| 52 Week High 5.50 | 52 Week Low 1.52 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RNXT Daily Charts |
RNXT Intraday Charts |
Whats New @ Bazaartrend |
RNXT Free Analysis |
|
|
RNXT Important Levels Intraday
| RESISTANCE | 2.15 |
| RESISTANCE | 2.08 |
| RESISTANCE | 2.04 |
| RESISTANCE | 2.00 |
| SUPPORT | 1.88 |
| SUPPORT | 1.84 |
| SUPPORT | 1.80 |
| SUPPORT | 1.73 |
RNXT Forecast May 2024
| 4th UP Forecast | 6.04 |
| 3rd UP Forecast | 4.73 |
| 2nd UP Forecast | 3.91 |
| 1st UP Forecast | 3.1 |
| 1st DOWN Forecast | 0.78 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.85 |
| 4th DOWN Forecast | -2.16 |
RNXT Weekly Forecast
| 4th UP Forecast | 3.98 |
| 3rd UP Forecast | 3.33 |
| 2nd UP Forecast | 2.92 |
| 1st UP Forecast | 2.52 |
| 1st DOWN Forecast | 1.36 |
| 2nd DOWN Forecast | 0.96 |
| 3rd DOWN Forecast | 0.55 |
| 4th DOWN Forecast | -0.10 |
RNXT Forecast2024
| 4th UP Forecast | 10.36 |
| 3rd UP Forecast | 7.66 |
| 2nd UP Forecast | 5.99 |
| 1st UP Forecast | 4.32 |
| 1st DOWN Forecast | -0.44 |
| 2nd DOWN Forecast | -2.11 |
| 3rd DOWN Forecast | -3.78 |
| 4th DOWN Forecast | -6.48 |
RenovoRx Inc. Common Stock ( NASDAQ USA Symbol : RNXT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RNXT Business Profile
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Los Altos, California. Address: 4546 El Camino Real, Los Altos, CA, United States, 94022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service